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Introduction: Novel Psychoactive Substances (NPS), especially Synthetic Cannabinoid
Receptor Agonists (SCRAs), pose a substantial challenge to health and the security of the
prison environment. This study analyses the phenomenon from the perspective of people
in prison and that of professionals working with them.
Methods: A phenomenological qualitative approach was used to analyze self-reported
experiences with ‘Spice’ (NPS) among users in prison. A semi-structured questionnaire
was also disseminated among professionals working in these settings to better
understand (a) the impact of NPS on their work; (b) perceived issues on safety in their
working environment; (c) approaches used to tackle the phenomenon and best practices.
Results: Psychotic events resulting from the collected Spice accounts (5) were marked
by hallucinations, depression, self-harm, and suicidal ideations. Other emerging elements
included fear, paranoia, inability to be with others, mistrust, breakdown and other risky
behaviors. Overall, 186 responses from prison staff were collected across the country.
67% claimed NPS to have had a deep impact on their work as they commonly witnessed
espisodes involving outbursts of anger, slurred speech, hallucinations, psychosis, and
significant mental deterioration among those in prison. Some 91% have witnessed
aggression at least once, with 53% experiencing direct harm. Suggested interventions
included enhanced training and education (84%), improved detection (92%) and
treatment and support services (93%).
Conclusions: Findings highlight the urgent need for joint multi-disciplinary efforts to tackle
the exponential escalation of NPS in prisons as well as to facilitate the recovery andg May 2020 | Volume 11 | Article 4601
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valuable methods to study drug induced experiences.Keywords: novel psychoactive substances, spice drugs, prison system, violence, Synthetic Cannabinoid Receptor
Agonists (SCRAs)INTRODUCTION
Novel Psychoactive Substances (NPS) pose ‘the most serious threat
to the safety and security of the prison system’ (1). Emerging data
from British prisons are of great concern with an estimate range
between 33 and 90% of people in prison regularly using these
substances, especially Synthetic Cannabinoid Receptor Agonists
(SCRAs) (1, 2). NPS are typically analogs of other psychoactive
substances, created in makeshift laboratories without any safety
protocols or testing in humans, thus posing a severe health
challenge for this vulnerable population and professionals
working with them. Although prisons have comprehensive
security systems in place to detect contraband items, NPS more
easily evade standard detection methods, as they are often colorless,
odorless and active in very small quantities. In addition to the usual
methods of import such as hiding in bodily orifices, SCRAs have
also been sprayed onto clothing, food items, letters and even
children’s drawings sent into prisons. As the use of these drugs in
prisons has reached alarming levels, so has the number of cases of
self-harm, suicide attempts, aggressions and assaults, and
ambulance call-outs (2–4). According to the most recent review
of the Ministry of Justice, there were 308 deaths in custody in the
year to September 2019. Incidents of self-harm have risen by 22%
from the previous year and the number of assaults increased by 5%
up to June 2019, with a rate of 451 episodes of violence per 1,000
prisoners (5). The use of NPS in prisons has also been associated
with organized crime, bullying, debt and suicides (1, 6). Associated
violence can often extend to the wider community; the family and
friends of those who are experiencing addiction or accumulating
debts in prisonmay also be pressured to provide funds or carry NPS
into prison.
Overall, there are currently 118 prisons in England, each with
a dedicated healthcare team for prisoners. In 2018–19, 53,193
adults received treatment in such secure settings (99% of which
was in the adult prison estate) (7). Of these, 11% presented to
treatment services for NPS related issues, either on their own or
alongside other substances, up from 6% in 2015–16. Health risks
associated with NPS use include convulsions, paralysis,
tachycardia, psychosis, anxiety, depression, self-harm and
suicide. This is due to their higher potency and affinity for the
cannabinoid receptors CB1 and CB2 compared to THC. In
particular, the regular use of SCRAs has been associated with
aggressive behaviors and other psychotic symptoms, especially
among those already affected by addiction or mental illness (8).
More in detail, NPS use, and particularly SCRAs have been
linked with the diagnoses of bipolar disorder, personality
disorders and the onset of schizophrenia and related disorders
(9). Acute and long term consequences of NPS consumption may
have a number of important clinical implications, especially forg 2young users (10, 11). Incidents involving NPS also carry a higher
risk of hospitalization (88.9% of admission by drug with an
emergency medical treating was using SCRAs) compared with
traditional drugs (12). Furthermore, NPS use has been associated
with a high prevalence of fatalities (13). These figures may also be
under-estimated as NPS related fatal intoxications may be under-
investigated due to difficult and expensive methods of post-
mortem detection. Treatment is also challenging because of the
potential interaction between NPS and prescription medications
common in prison settings, such as benzodiazepines and other
psychotropic medications (9). Because of the novelty of the
phenomenon, training for health and other professionals
working in such settings has not kept pace with evolving
trends in drug use, resulting in a lack of confidence in some
staff responding to NPS related emergencies (14, 15). This study
aims evaluate the experiences of both people in prisons and
professionals working with them in order to inform the
development of new targeted responses. The study was
approved by the University of Hertfordshire Ethics Committee
(LMS/SF/UH/03868). Additional ethics approval was gained by
the National Research Committee (NRC) for the secondary
analysis of the accounts collected from Her Majesty’s Prison
Service (HMP) & Young Offenders’ Institution Parc.MATERIALS AND METHODS
Accounts from people in prison affected by NPS use were
collected at Her Majesty’s Prison Service (HMP) & Young
Offenders’ Institution Parc, which is Category B Training
Prison in South Wales, operated by G4S Custodial and
Detention Services. A selected number of individuals, known
to the substance misuse team as users of SCRA, also known as
‘Spice’, were approached by the Drug Strategy Manager and
informed about the study. Those who agreed to participate
prepared a written account about their experiences of using
‘Spice’. This was written either on their own, or with the support
of staff. The collected accounts have sometimes been edited for
clarity, but strongly reflect the submissions of each of the
individuals. These were analyzed according to a qualitative
phenomenological approach focusing on the assessment of
subjective experiences, through personal narratives, to trans-
personal constructs (16). Phenomenology is an increasingly
valued research methods in the context of clinical research for
bringing forth the typical feature(s) of personal experiences. In
our study, particular attention was given to the approach
proposed by Paul Ricoeur , which emphas izes the
conceptualization of the participant as an ‘agent’, a self among
other selves, in an effort to experience freedom (17). WrittenMay 2020 | Volume 11 | Article 460
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potentially identifiable data included in this article.
In addition, a semi-structured questionnaire was designed
and disseminated among professionals working in prisons and
acute mental health settings via a previously established network
of collaborators. The tool consisted of 19 questions on four
different themes: (a) basic demographic information; (b)
knowledge of NPS and impact on their work; (c) issues of
perceived safety in the working environment; (d) approaches
used to tackle the phenomenon and best practices. The
questionnaire was created on Qualtrics, a cloud-based software
developing online surveys that provides data analysis, sample
selection, bias elimination, and data representation tools.
Responses to the questionnaire were collected both in person
and online and anonymized. Face-to-face interviews with a
selected number of staff also took place. Research material was
securely stored and shared only between members of the
research team. A group of ex-offenders, currently undertaking
a degree at the University of Westminster, was consulted at
different stages in order to facilitate the development of the study
material. All participants gave individual informed consent to
participate in the study and further authorization was obtained
from the heads of prisons where the questionnaire
was disseminated.DATA ANALYSIS AND RESULTS
ASSESSMENT
Analysis of ‘Lived Experiences’ With NPS
Among People in Prison
Five case studies were collected and analyzed according to a
phenomological approach.
Case 1:Fronti“I first used Spice in 2013 in prison, my mate gave it to
me. I didn’t know what it was but it blew my mind. The
vents at the back of the cell were moving, it looked like a
mouth so I thought they were talking to me. I moved to
another prison and was just using it all the time. I got
into debt, I was stressed out all the time and it didn’t
help that I was in a cell with my Uncle who was
pressuring me to get more and more. I ended up
having a breakdown because of it all, and tried to
throw myself off the 3s. Just before my breakdown I had
a really bad trip. I saw a hole in the floor of my cell, and
when I looked down into it I was pulled down and I am
convinced I went to hell. There was a wrinkly dog that
had a big studded collar on. I was shitting myself, really
scared, and then my Uncle who has passed away since,
pulled me back out and told me it wasn’t my time. Spice
is great when you’re on it, when I’m off it’s the worst I’ve
ever been. After I heard about my friend dying from it,
it really shook me up. I realised I was 33 and had
nothing to show for my life. I moved out of the cell with
my Uncle and have been determined to stay away fromers in Psychiatry | www.frontiersin.org 3it. I want more for myself.” JP. 32 years old, White
British, Level 1 Literacy, Entry 3 NumeracyAnalysis: JP shows a very high awareness of his experience
with Spice, recalling vivid memories of the first time and most of
all the ‘bad trip’, which seems to mark a turning point. He
presents with a complex multimodality anomalies of perceptions
where illusions and hallucinations (visual, audiotry and tactile)
were mixing. The abnormalities of perception are mood
congruent with his despair. The subject is dragged to a ‘dark
hole’ that he identified with hell. Of particular relevance is also
the second part of the experience, where the others in the story—
the mate and the uncle intervened and saved him. This element is
very important because although the contest of the perceptual
abnormalities was the same, his experience changed with the
introduction of the salvific role of the recently deceased uncle,
who saved him from hell and therefore from the ‘bad trip’. When
experiencing hell only others around us can offer a glimpse of
hope in order to recover our true self. Despite all good intentions
and determination, JP knows he needs a hand to overcome the
cycle of stress, debt and breakdown which will inevitably take
him back to hell. But his cry for help—wanting more for himself
—cannot be silenced.
Case 2:“I’ve never felt so afraid ever in my life of dying. I think
of loads of reasons why I shouldn’t take spice but it’s
that massive cloud of rush that comes all over my whole
body that keeps me saying ‘yes I want it’. It started 7
years ago. I’d been released from prison homeless and
went into town to see who was about, and saw a group
of boys making a spliff. I just thought it was skunk so
didn’t ask any questions and just took 6 long drags and
held it in. It was Christmas time so there were people
everywhere and the paranoia kicked in. I was walking
through crowds of people and everything was zooming
in and out, the people and the buildings, and it was just
like being in a weird bubble with everything echoing
around me. That should have been the end. Spice is the
only drug where I hear a voice saying ‘you’re going to
die, you’re going to die’. That alone should be enough
for me to stop smoking it but it’s not. But at the same
time I don’t want to die. I certainly shouldn’t enjoy
spice if that voice keeps telling me I’m going to die, and I
honestly don’t want to leave prison in a body bag. But I
can’t stop. Spice scares the shit out of me but when I get
the urge to score some more, it’s not that I forget about
the scary signs, I just make the effort to forget them.
That scares me even more.” GC. 35 years old, White
British, Entry 1 literacy, entry 2 numeracy.Analysis: The fear of death, in itself traumatic, is accentuated
when experienced, as in GC’s case, under the influence of Spice.
The awareness of finitude and fallibility is pushed by GC to its
limit when recognising that he is able to push away the ‘scary
signs’—the voice inside him—so as to satisfy ‘the urge’. This
ability to forget, and in a way to trick himself, is indeed evenMay 2020 | Volume 11 | Article 460
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contradiction, despite the many reasons he can list to stop taking
Spice. The phenomenological analysis also shows a significant
change in the quality of the experience expressed by the
evolution of the psychopathology. The individual’s symptoms
starts, when using spice, with complex multimodal illusions
(mainly visual) and evolve to audiotry hallucinations with a
voice making terrifying remarks. Under the influence of the
drugs, therefore, the patient has an experience similar to the one
that individuals with schizophrenia have.
Case 3:Fronti“I started smoking Spice in 2016 in prison. Subby
(Subutex, i.e. Buprenorphine) was my thing at the
time, when I couldn’t get that I was told I was told
smoking Spice would help with my withdrawals, so I
started smoking small amounts of it but it wasn’t doing
what my friend told me it would, so I started smoking
much more. Bigger the pipe the better as it’s called in
here. When Code Blueing (needing emergency health
attention in prison), the only way I can describe it’s like
going into an epileptic fit where you blank out and come
around feeling really stoned, so being high like you
would when you smoke weed, but if you’re not used to
Spice you go into instant paranoia, you feel like all the
walls are caving in on you, and when you lie on the bed
it feels like you’re sinking into it. Smoking Spice took me
to a really dark place, got to a point where I was so
paranoid and thought everyone was out for me. I didn’t
even feel safe walking to get my dinner and I lost 3 and
a half stone in weight as I thought that people were
putting poison in my food. The more I smoked the more
in debt I got, and didn’t really care what would happen
to me. It’s so addictive that getting more was all I cared
about. I was even letting people give me happy slaps or
punches to the face so I could get my fix. It was mentally
draining, I was getting no sleep whatsoever, getting
really bad cramps in my stomach. Seeing people smoke
Spice goes through me as I know what it did to me. I fell
out with my family as I was constantly asking for
money, making up lies like saying my trainers had
been robbed from the cell but really I’d sold them to get
a bit of Spice. I got to the point where I’d sold everything
in my cell, even my last shower gel and last toothpaste, I
even sold my TV to someone on basic (basic regime on
the prison IEP scheme), so that I could get high for the
next hour and spent the rest of the day just looking at
the walls. I’ve even drunk washing liquid from the
washing machine to get Spice from someone. It
ruined my life, I stopped speaking with my family for
years because I chose to smoke Spice, it takes you to a
really dark place where you have no respect for anyone
and you don’t give a shit about yourself. At one point, I
didn’t shower for three and a half months. When I last
got out of jail I carried on smoking Spice and smoked a
strong strand of Mamba with two friends, we all ended
up in hospital, one of my mates died and the other onesers in Psychiatry | www.frontiersin.org 4got to wear a colostomy bag for the rest of his life.
Luckily enough nothing bad happened to me but it
made me take a long look in the mirror and I thought I
need to change now or end up in a body bag and so
since that happened I can’t even stand the smell of
Spice. If anyone was thinking about starting to smoke
Spice, I’d tell them to stay away from it, it ruined my
life. I’m doing much better now, all my family are
speaking to me, I’ve got my health back. So that’s my
story of the Devil’s drug, Spice.” RB. White British, 29
Years old, Entry Level 3 education literacy
and numeracy.Analysis: RB is the youngest of this group, but also the one
who has gone all the way ‘to a really dark place’ (and ‘mentally
draining’), and back: no respect for anyone or himself, falling out
with his family and loved ones, on a clear path towards self-
loathing and self-destruction and carrying on smoking Spice
when out of jail. Only when a mate died and another one
remained permanently injured he managed to ‘take a long look
in the mirror’. Redemption is seen here as a process of self-
reflexivity that awakens the inner-self to return to the original
conditions of selfhood. The first sign of this is re-establishing ties
with his family, being recognized and accepted again by them
and, in the end, also being ‘forgiven’, as full part of the course
of redemption.
Case 4:“I started smoking Spice in 2015 when I was in Cardiff
Prison. I was introduced to it by my mate, I had no idea
what it was before I took it. It numbed me and made me
feel nice, but i know you can die from it which isn’t
good. I was stressed and bored and I used to numb that,
but I was getting stomach cramps because of it. I didn’t
really have anybody around me looking out for me, my
Dad died when I was young and I lost my girlfriend to
an overdose, so there’s been a lot of trauma in my life
and Spice blocks all that out. When I moved into a cell
with somebody who was using all the time it dragged
me down, but since moving in with my new padmate, I
feel more encouraged to stay away from it, I’m back in
the gym, I’ve got myself a job on the wing and I’m doing
much better. My advice to anyone thinking of using
Spice is don’t start it, because you can’t stop.” LD.
White British, 35 Years old, Entry Level 3 literacy and
numeracy in education.Analysis: LD’s story helps us to place his narrative in a wider
scenario, beyond prison and prior to the encounter with drugs or
Spice in particular. This is the case also in other accounts, but
here the ‘trauma’ takes the shape of specific faces of loved ones—
his father and his girlfriend—who are dearly missed. But
blocking trauma with Spice is an illusion, and while some
might influence negatively, others (even prison mates)
encourage him to take a different path.May 2020 | Volume 11 | Article 460
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gave a mate a lift. I was only taking him about half a
mile. When my mate got in the car he was rolling up a
spliff, he told me it was Spice and I’d heard a bit about it
but never had it. I had a couple of puffs whilst we were
driving and i got carried in the conversation and kept
smoking without realising. Once he’d got out of the car I
realised I couldn’t drive anymore, it was a really rapid
onset, not as fast as when you’re pinnin’ but really
quick. I dunno how much he’d put in there, but it
affected me really badly. I started off feeling really
relaxed, which is why I guess they link it to cannabis,
but it intensifies really quickly. I had no control of my
limbs, hands, arms, legs, couldn’t move them if i wanted
to. luckily I was on my own so I didn’t feel too paranoid.
I definitely would have panicked with people around
me. After a while, I thought I was OK, so tried to drive,
but quickly realised I was doing it really badly. I got
stopped by the police a short while down the road,
managed to convince them I was just really tired and
after breathalysing me they let me go. Never used it
since, and I’d never use it again. I’m a regular drug
user, including heroin, but Spice really is the bottom of
the barrel.” MD. 56 years old. Level 2 literacy and
numeracy. Mixed origin, British.Analysis: One single experience by MD was enough to
convince him to stay away from Spice. As an older and
‘regular drug user’ he was fully aware that Spice was ‘the
bottom of the barrel’, given the paralysing effect of this drug.
This account makes reference to the lesser detectability of
SCRAs, which has contributed to their popularity.
Survey Results Among Professionals
Working in Prison
Study Sample
Overall 186 individuals (92 females; 93 males), aged 25–65, took
part in the study. Participants belonged to different occupational
sectors, including prison and probation services (70%), clinical
and health care (15%), education (3%), social work/care (2%)
and to a lesser extent to business administration, Government
facilities, Public Health, Human Rights, and Police (Table 1).
The majority of participants (76%) were working in a prison
setting, 7% reported working in such environments
predominantly, 8% sometimes, 8%’rarely or never worked in
prisons; two participants had previously worked in prisons but
no longer did so. 45% of the sample had worked in prisons for
more than 10 years; 15% for 5–10 years, 15% for 2–5 years, 10%
for 1–2 years; 7% of participants had 6–12 months experience.
8% had been working there for less than 6 months.
Impact of NPS on Staff Working Environment
The majority of respondents considered their work “largely
affected” by NPS (81%). All participants agreed that NPS have
a negative impact on their working environment. Operationalers in Psychiatry | www.frontiersin.org 5instability, bullying, potential staff corruption, and time
constraints were also mentioned as contributing factors during
the interviews. Limited access to training opportunities was
another influencing factor. A participant stated: “The amount
of emergency health care codes makes the planned work too
much difficult” (Table 2).
Violence and Aggression
For the majority of the sample, outburst of anger, aggression and
violence were of great concern. While 9% stated to have never
seen any aggression, others witnessed it at least once or twice
(9%), less than 10 times (18%), more than 10 times (28%) and
more than 50 times (36%) (Table 3).
Overwhelmingly, respondents thought that NPS were the
main cause for such episodes. While 47% have never
experienced direct harm, such as an assault, 13% declare to
have been a victim of it (or to know a colleague with such a
history behind) on one occasion, 21% between two and five
times, 19% more than five times (Table 4).
Substances
Survey participants reported witnessing, or being otherwise
aware of, use of a number of other substances in the prisons in
which they work (Figure 1). These included cannabis (14%),
heroin (7%), alcohol (14%) and also drug replacement
medication or other prescription drugs, such as methadone,
gabapentin, pregabalin, «Oids» (steroids), buprenorphine, and
painkillers (14%).
During the interviews, staff also mentioned the deliberate
consumption of products with the intention of inducing an
intoxicated state. These included rat poison, alloy wheel
cleaner, and bug killer repellant among others. It is not clear
whether these are examples of ‘urban myths’ or hear-say, or first-
hand observations. The likelihood of a person in prison being
able to access some of these items is remote. “I work on a
substance misuse induction wing and a recovery wing as an SMS
worker so see and deal with a lot of hardened substance users.
There is a regular supply of drugs with “Throw overs” and new
receptions although there is now a body scanner in place so the
new reception supply has reduced. The prisoners will use any
form of NPS largely without questioning. Valium is very popular
at the moment and buprenorphine snorting and concealment is
popular although the prison is very restrictive with its issue.
There is a lot of pressure on prisoners who are in receipt of
ADHD meds to conceal them and pass them on. Tablets like
Pregablin are regularly chased by prisoners seeking additional
drugs or to conceal and sell on”.TABLE 1 | Q. What is your occupational sector?
Occupational sector %
1 Clinical and Health care 15
2 Education 3.2
3 Social work and care 1.6
4 Prison and probation services 70.4%
5 Academia 0.5%
6 Other 9.1%May 2020 | Volume 11 | Article 460
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a considerable increase in the number of ambulance callouts and
hospitalizations that they witnessed (more than 10 times for 52%
of the sample; see Figure 2).
Safety
Although the large majority of the sample felt ‘reasonably’ (51%)
or ‘completely safe’ (13%), 25% felt ‘unsafe at times’ and 5%
‘often unsafe’. Some participants (6%) were not aware of the level
of risks they were facing (Table 5).
All the participants agreed that NPS has a negative impact on
their safety with 37% of them considering the risk ‘extremely
high’, 38% ‘high’ and 19% ‘substantial’. Only 6% found a
marginal impact on their safety (Table 6).
Health-Related Harms
As shown in Figure 2, the most observed health-related harms
were ‘short-term mental health issues’, such as hallucinations,
psychosis, slurred speech, and a significant mental deterioration.
45% of the sample dealt with such issues more than 10 times in
their life, 21% between five and 10 times, 21% less than 10 times
and 4% only once; while 9% none. Half of the interviewees
reported to have witnessed more than 10 hospitalizations or
ambulance call-outs due to NPS. A clinician observed: “NPS use
contributes to the worsening of existing psychosis and to the
presentation of new psychotic episodes”.TABLE 2 | Impact of NPS on staff working environment.
Issue Description
Aggression/
Violence
« It is difficult to get people to listen, to respond. They may be
agitated, unreasonable, aggressive. Their priorities are not around
progress and growth »
« Affects vary from adverse health effects, to violence related to
debt (this includes being assaulted through not being able to pay
off debt, being violent to others to pay off debt, or violent as a side
effect to use). Self-harm also linked with inability to manage use of
NPS. Use of NPS has impacted on men attending work or
education, as well as gym sessions and programs. »
« We have noticed Increases risk of self-harm and suicide attempts,
increases risk of violence towards others. »
« …Increased levels of violence, bullying others to use to test drug
levels, medical issues, falling over, sliding down walls, no
recollection of their behaviors. »
Time
constraints
« The impact it has on users renders them unable to keep
appointments and/or progress. It can also kill them. The
spice use within the wings and the prison regime frequently
leads to lock downs due to incidents, so again it’s
impossible to keep appointments scheduled and many,
many meetings have been cancelled. »
«It has impacted my ability to interview offenders for report and
assessments. I have had to terminate these appointments and
reschedule. NPS also affects the work that we are trying to do to
rehabilitate offenders. It negates all the effects and support that is
provided. »
« We all noticed a failure to attend for interview for sentence
planning. They are unable to work and get into debt, under threat
… and many of them are coerced to do things. As a result, this is
disruptive for the prison regime. »
« It breaks up the normal day and the Prisoners who would have a
full educational session only receive limited time with the Teacher/
Instructor. »
Safety « NPS lead individuals in a zombie like state requiring
further staff intervention with regards to their safety. This in
turn destabilizes the regime and causes problems for non-
NPS inmates. NPS can also lead to aggressions towards
staff and others and it is largely responsible for most of
debts and bullying in prison. »
« It has made the pressure on support services increase. It has
increased the level of debt. It has led to more severe and
sometimes fatal health issues. It demotivates prisoners. It has
made the prison environment less safe. »
Health « There is a lack of concentration, a lack of motivation to do
anything other than use NPS. »
«NPS have an impact on many things.
On their engagement,
on their physical health,
on their mental health.
A cycle of events that lead them to continue their use.
They can’t function
They can’t work »
« Prisoners heavily using NPS can ‘fall apart’. They have no interest
in personal hygiene, they often sell their food and of course lose
weight rapidly»
« Working with individuals with extreme NPS addictions is difficult
even when they are not under the influence at the time, they are
often forgetful and experience extreme mental health issues. NPS
makes drug users experience a variety of health problems that also
interfere with their engagement, to attend health care appointments
or because they are generally unwell.
I have encountered individuals who have had strokes due to NPS
use and this has damaged their ability to engage with rehabilitation
in prison due to a lack of specialized care for these types of long
(Continued)TABLE 2 | Continued
Issue Description
term conditions. »
« Some prisoners have had to be transferred to psychiatric
inpatient units. Instances whereby some have completed stopped
eating due to paranoia that the food is poisoned, others have
completely refused all medication, either to help manage their
mental state as a result of NPS use or medication to manage their
pre-existing health conditions, such as diabetics or epileptics. »TABLE 3 | Q. In the past year, have you seen any episodes of violence or
aggression within the prison setting?
# Answer %
1 More than 50 times 36%
2 More than 10 times 28%
3 Less than 10 times 18%
4 Once or twice 9%
5 No never 9%May 2020 | Volume 11 | ArticleTABLE 4 | Q. Have you or a colleague (in your presence) ever experienced
direct harm, such as an assault, which you believe to be related to the use of
NPS?
# Answer %
1 Yes on multiple occasions (more than five times) 19%
2 Yes, between two and five times 21%
3 Yes on one occasion 13%
4 No, never 47%460
Corazza et al. Novel Psychoactive Substances and the Prison SystemLess common were ‘short-term effects on physical health’,
such as seizures or tachycardia, and long-term mental health
issues. It is interesting to notice that 29% of interviewees have
‘never observed long-term physical health problems’ among
inmates using NPS.
The main acute clinical consequences which were related to the
consumption of NPS were represented by both ‘severe mental
disturbances’, such as consciousness alterations or psychotic
symptoms onset or exacerbations, and ‘disrupting behavioral
abnormalities’, such as mostly dyscontrol, aggression and violence.
These symptoms are not unique to any diagnosis, and often residents
displaying these behaviors do not neatly satisfy the diagnostic criteria
for any condition (such symptomsmay be common in several mental
disorders, or acute states). Such evidence confirms that a wide range
of potential aspecific and mixed psychotic, affective and behavioral
responses are reported as a result of NPS consumption. A general lack
of self-care and personal hygiene was also perceived, as a healthcare
professional stated: “Prisoners heavily using NPS can ‘fall apart’. They
have no interest in personal hygiene, they often sell their food and of
course lose weight rapidly”.
As a participant stated: “Patients are referred into mental
health clinical settings following the use of NPS in prison.Frontiers in Psychiatry | www.frontiersin.org 7Diagnosis and management of presentation is increasingly
difficult along with associated risks of violence and aggression
for prolonged periods. Current clinical solutions are ineffective for
longer periods until the substances begin to clear from the patient
which can take several weeks. Until this time, medications have
little clinical effect and there are no adequate means of containing
disturbed behavior, even within Psychiatric Intensive Care Unit”.
Concerns for their own health also emerged, including risks
related to the secondary exposure to potentially highly toxic
substances, as NPS are introduced to prisons via drones, letters
and other hidden channels, such as food deliveries and
children’s drawings.
Approaches Used to Tackle the Phenomenon and
Best Practices
A number of suggested approaches for managing NPS in prisons
were rated by participants using a 5-point Likert scale.
Knowledge and Education Needs
Some 59% of the respondents rated their knowledge on NPS
‘sufficient’ (Table 7), but they strongly highlighted the need for
training and more information on NPS, mainly to be deliveredFIGURE 1 | Q. Are you aware of one or more prisoners using one of the following substances?May 2020 | Volume 11 | Article 460
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Frontiers in Psychiatry | www.frontiersin.org 8via face-to-face workshops (29%), conferences (19%),
newsletters (17%), scientific articles (10%), online programs
(9%), among others (Table 8). Only 3% indicated the use of
mobile phone app as a preference, possibly due to the limited use
of the tool in such high-security settings.
Improving Current Detection Tools
The majority of interviewees (92%) reported a need for
‘improving current detection tools’ (see Figure 3).
Expanding Treatment and Support Services for Those With
Drug Addiction or Mental Health Problems
Some 93% expressed the need for ‘expanding treatment and
support services for those with drug addiction or mental health
problems’. They found that a better understanding of the
underlying psychopathological issues will help the development
of better assessment tools and both pharmacological and non-
pharmacological treatment of those affected.FIGURE 2 | Q. Have you seen people in prison experience health-related harms which you believe to be due to NPS use?TABLE 5 | Q. Do you feel personally safe in your work in prisons?
# Answer %
1 Yes, completely safe 13%
2 Yes, reasonably safe 51%
3 I don’t know 6%
4 Unsafe at times 25%
5 Unsafe often 5%TABLE 6 | Q. To what extent do you feel the use of NPS affects the safety of
those working in prisons?
# Answer %
1 No affect 0%
2 A small effect 6%
3 A substantial effect 19%
4 A large effect 38%
5 An extremely large effect 37%May 2020 | Volume 11 | Article 460
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Frontiers in Psychiatry | www.frontiersin.org 9Another major barrier to treatment was the fact that inmates
using NPS often refused to participate in rehabilitation activities,
making their attempts even harder. It was claimed that negative
and disruptive behaviors often sabotaged the therapeutical bond
between prisoners and staff. A respondent said: “I work in a
medium secure unit. Many of the patients use NPS. This makes it
difficult for them to sustain relationships with staff, or engage full
in psychological therapy. It affects patients’ mental states
negatively, and slows up discharge”.Offering Alternative Activities Including Expanded
Educational and Prison Employment Opportunities
Making available ‘better education programs for people in
prisons about NPS’ was found essential by the large majority
(84%) of the participants. Some found that the prison
environment often restricted offenders’ access to learning
opportunities. According to them, training sessions were often
cancelled due to ‘Spice’ incidents and staff being assaulted.
The development of Continuing Professional Development
(CPD) courses for prison staff around NPS was also strongly
supported (84%). As a participant stated: “The answer lies withinTABLE 7 | Q. How would you rate your knowledge and awareness of NPS?
# Answer %
1 Excellent 23%
2 Sufficient 59%
3 Not sure 7%
4 Somewhat insufficient 9%
5 Minimal 2%TABLE 8 | Q. If you were to learn more about NPS and the implications for your
work, how would you prefer to receive this information?
# Answer %
1 Conference attendance 19%
2 Webinar 3%
3 Face-to-face workshops 29%
4 Online CPD program 9%
5 Email bulletin/Newsletter 17%
6 Reference Website 7%
7 Mobile App 3%
8 SMS with updates/trends 3%
9 Scientific Literature/Academic articles 10%FIGURE 3 | Q. What do you think is most needed to tackle the use of NPS in prison?May 2020 | Volume 11 | Article 460
Corazza et al. Novel Psychoactive Substances and the Prison Systemprevention—we need to do all we can to prevent these items
coming in. If we can achieve that or significantly reduce that—we
have a better chance of getting these men clean and substance
free and then we can work on interventions—i.e. substance
misuse awareness, better education”.
Increasing Support for General Prison Populations, Such as
Peer-To-Peer Support, Mentoring, Guidance, Counselling,
Wellbeing Services
About 82% also encouraged the provision of additional learning
and employment opportunities for people in prisons.DISCUSSION AND CONCLUSION
In a situation of emergency, our work provides a ‘first-hand’
perspective on ‘Spice’ (NPS) as experienced by people in prison
in combination with the views, the concerns and the
recommendations for best practices from professionals
working with them. The phenomenological analysis of the five
accounts shared by Spice users in prison allowed us to gain
original insights on the underlying ‘feeling of paranoia’, such as
the inability to be with others and the mistrust towards them. In
one case the paranoia was so deep to generate prolonged periods
of discomfort resulting in a complete breakdown. Psychological
(and possibly physical) dependence was another common
feature that emerged from our analysis. This was associated
with unpleasant withdrawal symptoms. Psychotic outbreaks
were marked by hallucinations, depression, suicidal ideations.
Other negative experiences included self-harm, fear of death or
seeing others dying or losing a friend. Even the language used to
describe the experience was charged with negative connotations,
such as: ‘going to hell’ (a hole in the floor), a ‘dark place’, hearing
voices predicting one’s death, ‘the Devil’s drug’, and ‘bottom of
the barrel’. Taking Spice with others was perceived also as a way
to overcome boredom due to lack of engaging and stimulating
activities. Interestingly, some therapeutical elements could also
be found in the narrative of these experiences. For instance, in
the first case (JP), the hallucinatory experience changed from
‘despair of hell’ to ‘redemption’mediated by a savior represented
by the recently deceased uncle. This allows us to confirm the
validity of the phenomenological approach to uncover the more
hidden aspects of a person’s inner world that would not be
accessible otherwise and that could be used in future applications
to address trauma and other causalities that perpetuate the
misuse allowing new cues to emerge. Further, all the collected
‘lived experiences’ were part of a wider narrative, or “life-story”.
The residents’ willingness to share their stories with Spice reflects
a positive attitude aimed to regain the (self-)esteem and the
recognition granted to them by the external community, which
should be encouraged during the rehabilitation process. These
findings well integrate with the results that emerged from the
survey and the interviews with a wide range of professionals
working in custodial settings. These helped us to shed new
insights on the impact of NPS on their working environments,
compared to that previously posed by other non-NPS substances.Frontiers in Psychiatry | www.frontiersin.org 10Although the majority of the sample had not been personally, or
directly, affected by episodes of violence, a number of concerns
were reported. Participants referred to their struggle to deal with
the violent behavior of residents, resulting in aggressions
between them, or towards staff members. Despite various
mechanisms being in place, they highlighted the need for
specialist training for those expected to respond to medical or
welfare emergencies arising from use of NPS. Their unwanted
exposure to potentially lethal or highly toxic substances was also
emphasized. During the interviews, it was noticed that NPS were
often misleadingly labeled by them as ‘Spice’, when in fact the
term refers to only one category of NPS, SCRA and does not
include a wide range of other substances. This discordance in
understanding of what we mean by NPS constitutes a further
challenge for clinicians and paramedics, since, as they stated,
“they might be unaware of what they have taken and how”. As a
result, a “treat what you see” approach has been adopted, and
while still being the most indicated approach in acute medicine,
the full implications of this, along with all potential drug
interactions with other medications, are not fully understood.
The challenge of responding to drug-related psychotic episodes,
and the variability and the unpredictability of acute symptoms
were other issues of concern that emerged from our study. These
did not differ substantially from those commonly observed
outside of custodial settings, such as emergency departments,
where reported cases are characterized by clinical signs of acute
mental intoxication with a mixed symptom profile, not meeting
the psychopathological criteria of any specific mental disorder.
However, this plays an even more serious role in the prison
environment, increasing the perception of risk and difficulty to
manage situations by the staff. As previous argued (8), the
accurate collection of data on the use of NPS, investigations,
treatment, violence pre-admission, violence during admission,
length of stay, and readmission should strongly be reinforced at
this challenging time. Finally, most of the interviewees strongly
emphasized the need for more educational programs to raise risk
awareness on NPS and facilitate their responsiveness to emergency
situations. This may play a major role to reduce threats to the health
of consumers, particularly with the appearance on the illicit market
of new highly potent compounds which may escape traditional
screening tests, such as Novel Synthetic Opioids (NSOs) (18). In
conclusion, the unprecedented outbreak of NPS in British prisons
exerted a negative influence on the overall psychological atmosphere
in such environments, enhancing the general level of alarm and
unsafety. Joint multi-disciplinary efforts are required to tackle the
phenomenon and facilitate recovery and reintegration into society.
The study presents various limitations. As far as we know, this is
the first time that a phenomenological approach has been used to
analyze drug related experiences. A small sample (5) was selected for
the investigation, which considering the positive results could be
further expanded in the future. Strict inclusion or exclusion criteria
were not provided for the selection of both our samples.
Furthermore, we did not investigate the type of prisons nor the
sociodemographic of the cohort. This may have led to potential bias
in the selection of the respondents. In terms of future research, a
larger study cohort would allow for the consideration of differencesMay 2020 | Volume 11 | Article 460
Corazza et al. Novel Psychoactive Substances and the Prison Systembetween the occupational sectors involved in terms of level of
awareness, personal experiences, feelings and needs perceived, and
of what has changed in professional practice. It is hoped that this
study could help to build a clearer picture of where already-
stretched resources may need to be focused and further extended
to capture data from a greater number of prisons, from a more
diverse professional cohort, and from wider territories, in particular
beyond the United Kingdom, where the phenomenon is probably
under-reported. The involvement of people in prison is also strongly
encouraged in future studies as well as the consultation with a group
of ex-prison residents to facilitate their implementation. Only a
major joint effort among different key stakeholders can tackle the
emergency caused by the spread of NPS in prisons and lead to the
development of effective treatment and rehabilitation measures.Fronti“I am a real person with a real experience. Studies can
be done until we are blue in the face. Let’s act now”. A
prisoner from HM Prison Guys Marsh (Dorset,
England), August 2018.DATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will be
made available by the authors, without undue reservation.ers in Psychiatry | www.frontiersin.org 11ETHICS STATEMENT
The studies involving human participants were reviewed and
approved by University of Hertfordshire. The patients/participants
provided their written informed consent to participate in this study.AUTHOR CONTRIBUTIONS
OC designed and coordinated the study and the preparation of
this manuscript. SC contributed to the data collection and
analysis. SM and AN contributed to the literature review and
the data collection. MV and CW collected the five case studies
from prisons. CZ and AM carried out the phenomenological
analysis. AA and SD coordinated the advisory group of ex-
offenders. RR contributed to the literature review and provided
clinical input. AA contributed to the phenomenological analysis
and provided clinical input. GB contributed to the coordination
of the overall project.ACKNOWLEDGMENTS
We would like to thank the people in prison and all those
working with them for sharing their valuable insights.REFERENCES
1. HM Inspectorate of Prisons. (2015). HM Chief Inspector of Prisons for
England and Wales Annual Report 2014-15. HM Inspectorate of Prison
2. Ministry of Justice and Safety in Custody Statistics, England and Wales.
(2019). Deaths in Prison Custody to September 2019 Assaults and Self-harm
to June 2019. 31 October 2019.
3. Ralphs R, Williams L, Askew R, Norton A. Adding spice to the porridge: The
development of a synthetic cannabinoid market in an English prison. Int J
Drug Policy (2017) 40:57–69. doi: 10.1016/j.drugpo.2016.10.003
4. Corazza O, Roman-Urrestarazu A. Handbook of Novel Psychoactive Substances.
What Clinicians Should Know about NPS. 1st Edition. London: Routledge (2018).
5. Abdulrahim D, Bowden-Jones Oon behalf of the NEPTUNE Expert Group.
Guidance on the Management of Acute and Chronic Harms of Club Drugs and
Novel Psychoactive Substances Vol. 2015. . London: Novel Psychoactive
Treatment UK Network (NEPTUNE) (2015).
6. The Prisons and Probation Ombudsman. (2015). New psychoactive
substances: Learning Lessons Bulletin - Fatal incident investigations. 1–5.
7. Public Health England (PHE). (2020). Alcohol and Drug treatment in secure
settings 2018-2019: report. Available at https://www.gov.uk/government/
publications/substance-misuse-treatment-in-secure-settings-2018-to-2019/
alcohol-and-drug-treatment-in-secure-settings-2018-to-2019-report.
8. Shafi A, Gallagher P, Stewart N, Martinotti G, Corazza O. The risk of violence
associated with novel psychoactive substance misuse in patients presenting to
acute mental health services. Hum Psychopharmacol: Clin Exp (2017) 32(3).
doi: 10.1002/hup.2606
9. Acciavatti T, Lupi M, Santacroce R, Aguglia A, Attademo L, Bandini L, et al.
Novel psychoactive substance consumption is more represented in bipolar
disorder than in psychotic disorders: A multicenter-observational study.Hum
Psychopharmacol (2017) 32(3):1–6. doi: 10.1002/hup.2578
10. Martinotti G, Lupi M, Acciavatti T, Cinosi E, Santacroce R, Signorelli MS,
et al. Novel psychoactive substances in young adults with and without
psychiatric comorbidities. BioMed Res Int (2014) 30(4):295–301.
doi: 10.1155/2014/815424
11. Martinotti G, Cinosi E, Santacroce R, Papanti D, Pasquini A, Mancini V, et al.
Substance-related psychopathology and aggressiveness in a nightlife holidayresort: Results from a pilot study in a psychiatric inpatient unit in Ibiza. Hum
Psychopharmacol (2017) 32(3):e2586. doi: 10.1002/hup.2586
12. Winstock AR, et al. Global Drug Survey (GDS) 2019 https://www.
globaldrugsurvey.com/wp-content/themes/globaldrugsurvey/results/
GDS2019-Exec-Summary.pdf.
13. Corkery JM, Schifano F, Martinotti G. How deaths can help clinicians and
policy-makers understand the risks of nove psychoactive substances. Br J Clin
Pharmacol Special Issue: New Psychoactive Substances (2020) 86(3):482–98.
doi: 10.1111/bcp.14183
14. Public Health England (PHE). (2017). New Psychoactive Substances (NPS) in
prisons: A toolkit for prison staff. Public Health England
15. Criminal Justice Joint Inspection. (2017). New Psychoactive Substances: the
response by probation and substance misuse services in the community in
England Crown copywright.
16. Stanghellini G, Ballerini M. Qualitative analysis. Its use in psychopathological
research. Acta Psychiatr Scand (2008) 117(3):161–3. doi: 10.1111/j.1600-
0447.2007.01139.x
17. Ricoeur P. (1960). Fallible Man, The Symbolism of Evil.
18. Marchei E, Pacifici R, Mannocchi G, Marinelli E, Busardò FP, Pichini S. New
synthetic opioids in biological and non-biological matrices: A review of
current analytical methods. TrAC Trends Analyt Chem (2018) 102:1–15.
doi: 10.1016/j.trac.2018.01.007
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
The reviewer GM declared a past co-authorship with one of the authors, OC, to
the handling editor.
Copyright © 2020 Corazza, Coloccini, Marrinan, Vigar, Watkins, Zene, Negri, Aresti,
Darke, Rinaldi, Metastasio and Bersani. This is an open-access article distributed under
the terms of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) and the
copyright owner(s) are credited and that the original publication in this journal is cited, in
accordance with accepted academic practice. No use, distribution or reproduction is
permitted which does not comply with these terms.May 2020 | Volume 11 | Article 460
